Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement
- PMID: 25409291
- DOI: 10.1001/jamadermatol.2014.2694
Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement
Abstract
Importance: The management of clinically atypical nevi/dysplastic nevi (CAN/DN) is controversial, with few data to guide the process. Management recommendations for DN with positive histologic margins were developed by the Delphi method to achieve consensus among members of the Pigmented Lesion Subcommittee (PLS) of the Melanoma Prevention Working Group (MPWG) after reviewing the current evidence.
Objectives: To outline key issues related to the management of CAN/DN: (1) biopsies of CAN and how positive margins arise, (2) whether incompletely excised DN evolve into melanoma, (3) current data on the outcomes of DN with positive histologic margins, (4) consensus recommendations, and (5) a proposal for future studies, including a large-scale study to help guide the management of DN with positive margins.
Evidence review: The literature, including recent studies examining management and outcomes of DN with positive margins between 2009 to 2014, was reviewed.
Findings: A consensus statement by the PLS of the MPWG following review of the literature, group discussions, and a structured Delphi method consensus.
Conclusions and relevance: This consensus statement reviews the complexities of management of CAN/DN. A review of the literature and 2 rounds of a structured Delphi consensus resulted in the following recommendations: (1) mildly and moderately DN with clear margins do not need to be reexcised, (2) mildly DN biopsied with positive histologic margins without clinical residual pigmentation may be safely observed rather than reexcised, and (3) observation may be a reasonable option for management of moderately DN with positive histologic margins without clinically apparent residual pigmentation; however, more data are needed to make definitive recommendations in this clinical scenario.
Similar articles
-
Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.JAMA Dermatol. 2016 Dec 1;152(12):1327-1334. doi: 10.1001/jamadermatol.2016.2869. JAMA Dermatol. 2016. PMID: 27542070
-
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.JAMA Dermatol. 2018 Dec 1;154(12):1401-1408. doi: 10.1001/jamadermatol.2018.3359. JAMA Dermatol. 2018. PMID: 30304348 Free PMC article.
-
The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.J Am Acad Dermatol. 2014 Dec;71(6):1071-6. doi: 10.1016/j.jaad.2014.08.025. Epub 2014 Sep 26. J Am Acad Dermatol. 2014. PMID: 25262175
-
[Dysplastic melanocytic nevus].Duodecim. 2010;126(21):2492-501. Duodecim. 2010. PMID: 21171474 Review. Finnish.
-
The "dysplastic" nevus.Clin Dermatol. 2009 Jan-Feb;27(1):103-15. doi: 10.1016/j.clindermatol.2008.09.008. Clin Dermatol. 2009. PMID: 19095156 Review.
Cited by
-
Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.J Am Acad Dermatol. 2017 Jan;76(1):121-128. doi: 10.1016/j.jaad.2016.07.029. Epub 2016 Sep 28. J Am Acad Dermatol. 2017. PMID: 27692732 Free PMC article.
-
Predictive Value of Positive Margins in Diagnostic Biopsies of Dysplastic Nevi.Dermatol Res Pract. 2020 Jan 29;2020:6716145. doi: 10.1155/2020/6716145. eCollection 2020. Dermatol Res Pract. 2020. PMID: 32180806 Free PMC article.
-
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.JAMA Dermatol. 2020 Sep 1;156(9):1004-1011. doi: 10.1001/jamadermatol.2020.1729. JAMA Dermatol. 2020. PMID: 32725204 Free PMC article. Review.
-
Using Implementation Science to Optimize the Uptake of Evidence-Based Medicine into Dermatology Practice.J Invest Dermatol. 2020 May;140(5):952-958. doi: 10.1016/j.jid.2019.10.011. Epub 2019 Dec 18. J Invest Dermatol. 2020. PMID: 31862108 Free PMC article. Review.
-
Pathologists' agreement on treatment suggestions for melanocytic skin lesions.J Am Acad Dermatol. 2020 Jun;82(6):1435-1444. doi: 10.1016/j.jaad.2019.12.020. Epub 2019 Dec 17. J Am Acad Dermatol. 2020. PMID: 31862403 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous